Summit Clinical Research Solutions announced it has unified Summit Clinical Research (SCR) and Pinnacle Clinical Research (PCR) under a single master brand, creating an integrated clinical research organization intended to streamline sponsor engagement and accelerate trial execution across the development lifecycle. The combined group is built around a connected ecosystem of site operations, partner-site networks, patient recruitment, medical communications, and early-phase clinical research organization (CRO) services.
The new platform brings together five coordinated service lines. Pinnacle operates a 14-site integrated research network noted for its work in metabolic dysfunction–associated steatohepatitis (MASH), metabolic disease, obesity, Alzheimer’s disease and other complex therapeutic areas. Elevation provides integrated research organization services and manages a global partner-site network of 120 sites in eight countries, extending sponsor reach while maintaining the strengths and local identities of affiliated sites. Apogee offers centralized patient recruitment and enrollment solutions aimed at improving speed, precision and patient engagement. Ascend delivers medical communications and scientific strategy services that support sponsors from development through commercialization, while Apex contributes specialized early-phase CRO capabilities for complex and emerging therapeutic programs.
Summit said these platforms together form a single clinical research ecosystem designed to reduce operational fragmentation, improve enrollment performance and deliver more consistent execution across programs. Across Summit-supported studies, affiliated sites—driven largely by Pinnacle—represent about 25% of trial sites but contribute more than 40% of enrolled patients on average. Since 2018, the organization has supported more than 50 sponsors across 115 clinical trials.
The rebranding follows a period of growth that has included expanded leadership in obesity, metabolic disease and Alzheimer’s disease, as well as continued investment in infrastructure, technology and site capabilities to handle increasingly complex development programs. Summit emphasized that the unified brand also reinforces its commitment to affiliated sites and CRO partners, and said it will continue to invest in and support the Elevation partner-site network with the infrastructure, collaboration and operational backing that have characterized its model to date.
“Bringing Summit and Pinnacle together under one brand reflects the way we already operate,” said Mazen Noureddin, MD, MHSc, FAASLD. He noted that sponsors, sites and partners already benefit from the integration of these capabilities, and said a unified Summit brand will make services easier to access, create greater consistency across engagements and strengthen the organization’s ability to support increasingly complex clinical development programs.